Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Audrey Mansuet-Lupo"'
Comparison of juvenile and adult myasthenia gravis in a French cohort with focus on thymic histology
Autor:
Frédérique Truffault, Ludivine Auger, Nadine Dragin, Jean-Thomas Vilquin, Elie Fadel, Vincent Thomas de Montpreville, Audrey Mansuet-Lupo, Jean-François Regnard, Marco Alifano, Tarek Sharshar, Anthony Behin, Bruno Eymard, Francis Bolgert, Sophie Demeret, Sonia Berrih-Aknin, Rozen Le Panse
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Myasthenia gravis (MG) is an autoimmune disease characterized by muscle fatigability due to acetylcholine receptor (AChR) autoantibodies. To better characterize juvenile MG (JMG), we analyzed 85 pre- and 132 post-pubescent JMG (with a cutoff
Externí odkaz:
https://doaj.org/article/3b000a0cb9d84470876edb122fb42735
Autor:
Kinan El Husseini, Hélène Lafoeste, Audrey Mansuet-Lupo, Jennifer Arrondeau, Clémentine Villeminey, Souhail Bennani, Marie-Pierre Revel, Marie Wislez
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 4, Iss , Pp 100101- (2021)
Immune checkpoint inhibitors have emerged as a cornerstone of management in non-small-cell lung cancer (NSCLC). They are responsible for a wide spectrum of immune-related adverse effects, which greatly differ from the adverse events of standard chemo
Externí odkaz:
https://doaj.org/article/bc696307854b4901b2bd85f1f3a2e915
Autor:
Diane Damotte, Sarah Warren, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Audrey Mansuet-Lupo, Jérôme Biton, Hanane Ouakrim, Marco Alifano, Claire Gervais, Audrey Bellesoeur, Nora Kramkimel, Camille Tlemsani, Barbara Burroni, Angéline Duche, Franck Letourneur, Han Si, Rebecca Halpin, Todd Creasy, Ronald Herbst, Xing Ren, Pascale Morel, Alessandra Cesano, François Goldwasser, Karen Leroy
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background The 18-gene tumor inflammation signature (TIS) is a clinical research assay that enriches for clinical benefit to immune checkpoint blockade. We evaluated its ability to predict clinical benefit of immunotherapy in cancer patients
Externí odkaz:
https://doaj.org/article/b75c5fd83d2d4639a48bed140c36dd2f
Autor:
Pascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, Jean-Philippe Durand, Elizabeth Fabre, Sixtine De Percin, Clémentine Vaquin Villeminey, Anne-Catherine Piketty, Nathalie Rassy, Guillaume Ulmann, Diane Damotte, Audrey Mansuet-Lupo, Frédérique Giraud, Marco Alifano, Marie Wislez, Jérôme Alexandre, Anne Jouinot, François Goldwasser
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103630- (2021)
Background: Immune checkpoint inhibitors (ICI) are dramatically active in a minority of non-small cell lung cancer (NSCLC) patients. We studied here the relationship between patients's metabolism and outcome under ICI. Methods: Metastatic NSCLC patie
Externí odkaz:
https://doaj.org/article/c752ad522f9e41baab6f8929446462cf
Autor:
Camille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, Ingrid Laurendeau, Claire Danel, Marc Riquet, Françoise Le Pimpec‐Barthes, Elizabeth Fabre, Audrey Mansuet‐Lupo, Diane Damotte, Marco Alifano, Armelle Luscan, Benoit Rousseau, Dominique Vidaud, Jennifer Varin, Beatrice Parfait, Ivan Bieche, Karen Leroy, Pierre Laurent‐Puig, Benoit Terris, Helene Blons, Michel Vidaud, Eric Pasmant
Publikováno v:
Cancer Medicine, Vol 8, Iss 9, Pp 4330-4337 (2019)
Abstract The tumor suppressor gene neurofibromin 1 (NF1) is a major regulator of the RAS‐MAPK pathway. NF1 mutations occur in lung cancer but were not extensively explored. We hypothesized that NF1‐mutated tumors could define a specific populatio
Externí odkaz:
https://doaj.org/article/1a977a17d1364953847cb9500545d65d
Autor:
Alice Guyard, Cécile Charpy, Nathalie Théou-Anton, Anne Cremades, Frédéric Grassin, Anaïs Bourgogne, Karen Leroy, Anaïs Pujals, Christiane Copie-Bergman, Christos Chouaid, Audrey Mansuet-Lupo
Publikováno v:
Translational Oncology, Vol 12, Iss 5, Pp 784-787 (2019)
Anaplastic lymphoma kinase (ALK) rearrangement is reported in 3% to 8% of patients with lung adenocarcinoma and can be detected by fluorescent in situ hybridization (FISH) or indirectly by immunohistochemistry. In FISH assay, isolated 5′ signal (lo
Externí odkaz:
https://doaj.org/article/417e1885bac74146a6c2267bde74831b
Publikováno v:
Cancers, Vol 14, Iss 6, p 1400 (2022)
Lung cancer is the most common cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) represents 80% of lung cancer subtypes. Patients with localized non-small cell lung cancer may be considered for upfront surgical treatment. Ho
Externí odkaz:
https://doaj.org/article/39224ca309d54a9ca0f6927ed7d7359e
Autor:
Anastasia Saade, Edith Carton, Audrey Mansuet-Lupo, Romain Jouffroy, Diane Damotte, Hélène Yera, Marie-Pierre Revel, François Goldwasser
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 12, Pp 2375-2378 (2018)
We report a case of chronic Schistosoma haematobium infection with pseudometastatic pulmonary nodules and high-grade squamous cell carcinoma in a 30-year-old man in Mali. Lung biopsies revealed chronic pulmonary involvement of S. haematobium and rule
Externí odkaz:
https://doaj.org/article/0fbe11371941451086e0ef7c38926be2
Autor:
Kinan El Husseini, Nouha Chaabane, Audrey Mansuet-Lupo, Karen Leroy, Marie-Pierre Revel, Marie Wislez
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 2, Iss , Pp 100024- (2020)
Unstructured abstract: Capmatinib, a highly specific MET inhibitor, was recently approved by the FDA for use in MET exon 14 skipping mutation-positive NSCLC. Although it is usually well tolerated, we describe the first case of a patient who incurred
Externí odkaz:
https://doaj.org/article/7ecedab2ae74405fa7ab5079ecb78b7c
Autor:
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoit Blanchet
Publikováno v:
Cancers, Vol 12, Iss 2, p 473 (2020)
A large interindividual variability has been observed in anti Programmed cell Death 1 (anti-PD1) therapies efficacy. The aim of this study is to assess the correlation of soluble PD-1 (sPD-1), soluble Programmed cell Death Ligand 1 (sPD-L1), Vascular
Externí odkaz:
https://doaj.org/article/13026479c4e74f20a32de966c4a6720f